Patient-Derived Organoids for Rectal Cancer

Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC

NCT05307198 ·Status: UNKNOWN ·Phase: PHASE2

Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer

NCT01012804 ·Status: WITHDRAWN

Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC-II-IV, With a 5-Fluorouracil-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.

NCT03034473 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening

NCT05304741 ·Status: UNKNOWN

Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer

NCT03053544 ·Status: COMPLETED ·Phase: PHASE2

Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision

NCT05772923 ·Status: RECRUITING ·Phase: NA

Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer

NCT01671891 ·Status: UNKNOWN

Non-operative Management for Locally Advanced Rectal Cancer

NCT03179540 ·Status: RECRUITING ·Phase: NA

Organ Preservation in Early Rectal Cancer Patients

NCT03548961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer

NCT03573791 ·Status: RECRUITING

A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer

NCT04852653 ·Status: ACTIVE_NOT_RECRUITING

Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer

NCT01613469 ·Status: TERMINATED ·Phase: PHASE2

Optimal Surgery and MRI Based Radiochemotherapy in Rectal Carcinoma

NCT01325649 ·Status: COMPLETED

Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer

NCT02423226 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Radiochemotherapy Combined With Panitumumab in Locally Advanced KRAS Wild-type Rectal Cancer

NCT01443377 ·Status: COMPLETED ·Phase: PHASE2

Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer

NCT01129700 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Adenocarcinoma of the Rectum With Transanal Local Excision for Complete Responders

NCT03941366 ·Status: UNKNOWN ·Phase: NA

Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma

NCT00682786 ·Status: COMPLETED ·Phase: PHASE2

Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

NCT04245683 ·Status: RECRUITING

Fluorescence Molecular Endoscopy and Molecular Fluorescence-guided Surgery in Locally Advanced Rectal Cancer

NCT04638036 ·Status: COMPLETED ·Phase: PHASE1

Study of High-Dose-Rate Endorectal Brachytherapy (HDRBT) in the Treatment of Locally Advanced Low Rectal Cancer

NCT01226979 ·Status: COMPLETED ·Phase: NA

Minimal Invasive Strategies for Good and Complete Response to Chemoradiation in Rectal Cancer

NCT00939666 ·Status: COMPLETED ·Phase: NA

Microbiome and Rectal Cancer

NCT04223102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Preoperative Radiotherapy and E7046 in Rectum Cancer

NCT03152370 ·Status: COMPLETED ·Phase: PHASE1

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

NCT04664504 ·Status: RECRUITING ·Phase: PHASE2